DUR BOARD QUARTERLY MEETING
Commission on Aging, Conference Room
3380 W. Americana Terrace
Boise, Idaho

January 15, 2004
9:00 AM

1. Approval of minutes from October meeting – R. Ting
2. Quarterly report on staff action since last meeting – V. Culbertson
3. Follow-up Intervention reports from third quarter
   1. Metformin Safety – C. Owens
   2. Statins in High-Risk Patients – T. Pettinger
   3. ACE Inhibitors in CHF – C. Owens
4. Current interventions
   1. Migraine Headache Treatment and Prophylaxis – C. Owens
   2. Proton-Pump Inhibitor Use –T. Pettinger
   3. COX-2 Inhibitor Use –C. Owens
5. Proposed interventions for first quarter 2004
   1. Off-label Gabapentin Use – C. Owens
   2. Appropriate Antibiotic Therapy for Strep Pharyngitis – T. Pettinger
   3. Appropriate Use of Palivizumab (Synagis®) – C. Owens
6. DUR Newsletter – C. Owens
   1. Statin Therapy
   2. Prescriber Numbers
   3. HIPAA and the DUR
   4. Cost Corner: Statins
7. Top 40 – C. Owens
8. Medicaid update – T. Eide
9. Other business
10. Future Meeting dates: March 18, June 17, September 16, January 20, 2005